NDS Notice Board

---

NDS Notice Board

• October 12, 2021

  Invitation for applications for NAPRA’s National Drug Scheduling Advisory Committee

  The National Drug Scheduling Advisory Committee (NDSAC) is a committee of the National Association of Pharmacy Regulatory Authorities (NAPRA) which serves to advise NAPRA on matters relating to the National Drug Schedules (NDS) program.

• October 7, 2021

  National Drug Scheduling Advisory Committee Meeting December 6, 2021

  The next meeting of the National Drug Scheduling Advisory Committee (NDSAC) is scheduled for December 6, 2021. The primary purpose of the meeting is to consider the following matter:

• October 5, 2021

  2022 Meeting Schedule for the National Drug Scheduling Advisory Committee (NDSAC)

  The following are the tentative meeting dates for the National Drug Scheduling Advisory Committee (NDSAC) in 2022. 

• September 30, 2021

  Mupirocin Scheduling Clarification

  The National Association of Pharmacy Regulatory Authorities (NAPRA) has received questions about the scheduling of mupirocin. Mupirocin is listed in Schedule I of the National Drug Schedules (NDS).

• August 25, 2021

  Policy for Drugs Not Reviewed – Mometasone Furoate

  The National Association of Pharmacy Regulatory Authorities (NAPRA) has received questions about the scheduling of mometasone nasal spray.

• July 28, 2021

  Final Recommendations for Non-Live Recombinant Herpes Zoster Vaccine and Bisacodyl 5mg Tablets

  The interim recommendations made by the National Drug Scheduling Advisory Committee (NDSAC) on June 6-7, 2021 that:

• July 22, 2021

  NDSAC Meeting of September 19-20, 2021

  The proposed meeting of the National Drug Scheduling Advisory Committee (NDSAC) September 19-20, 2021 is cancelled.

• June 30, 2021

  Fixed-Dose Combination Acetaminophen and Ibuprofen Schedule Clarification

  In July 2020, the National Drug Schedules (NDS) of the National Association of Pharmacy Regulatory Authorities (NAPRA) were amended to add the following listings:

• June 15, 2021

  NDSAC Interim Recommendations on Non-Live Recombinant Herpes Zoster Vaccine and Bisacodyl 5mg Tablets

  A meeting of the National Drug Scheduling Advisory Committee (NDSAC) was held on June 6-7, 2021 with the following interim recommendations made:

• June 2, 2021

  Ephedrine and Pseudoephedrine to Remain on the NAPRA National Drug Schedules Until 2024

  In accordance with its Policy on Natural Health Products (NHPs), the National Association of Pharmacy Regulatory Authorities (NAPRA) was to have removed all NHPs from the National Drug Schedules (NDS) on January 2, 2022.